Comparison of Pulmonary and Systemic NO- and PGI2-Dependent Endothelial Function in Diabetic Mice

Abstract EN

Diabetes increases the risk of pulmonary hypertension and is associated with alterations in pulmonary vascular function.

Still, it is not clear whether alterations in the phenotype of pulmonary endothelium induced by diabetes are distinct, as compared to peripheral endothelium.

In the present work, we characterized differences between diabetic complications in the lung and aorta in db/db mice with advanced diabetes.

Male, 20-week-old db/db mice displayed increased HbA1c and glucose concentration compatible with advanced diabetes.

Diabetic lungs had signs of mild fibrosis, and pulmonary endothelium displayed significantly ultrastructural changes.

In the isolated, perfused lung from db/db mice, filtration coefficient (Kf,c) and contractile response to TXA2 analogue were enhanced, while endothelial NO-dependent modulation of pulmonary response to hypoxic ventilation and cumulative production of NO2− were impaired, with no changes in immunostaining for eNOS expression.

In turn, 6-keto-PGF1α release from the isolated lung from db/db mice was increased, as well as immunostaining of thrombomodulin (CD141).

In contrast to the lung, NO-dependent, acetylcholine-induced vasodilation, ionophore-stimulated NO2− generation, and production of 6-keto-PGF1α were all impaired in aortic rings from db/db mice.

Although eNOS immunostaining was not changed, that of CD141 was clearly lowered.

Interestingly, diabetes-induced nitration of proteins in aorta was higher than that in the lungs.

In summary, diabetes induced marked ultrastructural changes in pulmonary endothelium that were associated with the increased permeability of pulmonary microcirculation, impaired NO-dependent vascular function, with compensatory increase in PGI2 production, and increased CD141 expression.

In contrast, endothelial dysfunction in the aorta was featured by impaired NO-, PGI2-dependent function and diminished CD141 expression.